CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

TSX:CHR • CA17040T8885

24.1 CAD
+0.33 (+1.39%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CHR. CHR was compared to 6 industry peers in the Passenger Airlines industry. CHR has only an average score on both its financial health and profitability. CHR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • CHR had positive earnings in the past year.
  • In the past year CHR had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
  • CHR had a positive operating cash flow in 4 of the past 5 years.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

  • CHR's Return On Assets of -2.62% is in line compared to the rest of the industry. CHR outperforms 50.00% of its industry peers.
  • Looking at the Return On Equity, with a value of -6.31%, CHR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Return On Invested Capital of CHR (6.40%) is better than 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CHR is in line with the industry average of 4.97%.
  • The last Return On Invested Capital (6.40%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROIC 6.4%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

  • With an excellent Operating Margin value of 6.81%, CHR belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • CHR's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CHR (65.68%) is better than 100.00% of its industry peers.
  • CHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.81%
PM (TTM) N/A
GM 65.68%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for CHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • CHR has an Altman-Z score of 0.94. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CHR (0.94) is comparable to the rest of the industry.
  • CHR has a debt to FCF ratio of 10.63. This is a negative value and a sign of low solvency as CHR would need 10.63 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 10.63, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.50 indicates that CHR is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CHR (0.50) is better than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Altman-Z 0.94
ROIC/WACC0.76
WACC8.42%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.22 indicates that CHR should not have too much problems paying its short term obligations.
  • CHR has a Current ratio of 1.22. This is in the better half of the industry: CHR outperforms 66.67% of its industry peers.
  • A Quick Ratio of 0.63 indicates that CHR may have some problems paying its short term obligations.
  • CHR has a Quick ratio of 0.63. This is comparable to the rest of the industry: CHR outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.63
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 58.94% over the past year.
  • Measured over the past years, CHR shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.51% on average per year.
EPS 1Y (TTM)58.94%
EPS 3Y-9.92%
EPS 5Y-3.51%
EPS Q2Q%-5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.33%

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.34% on average over the next years.
  • The Revenue is expected to decrease by -2.14% on average over the next years.
EPS Next Y-16.67%
EPS Next 2Y-3.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.59%
Revenue Next 2Y-2.59%
Revenue Next 3Y-2.14%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.04, which indicates a very decent valuation of CHR.
  • 100.00% of the companies in the same industry are more expensive than CHR, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of CHR to the average of the S&P500 Index (26.83), we can say CHR is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 12.05, CHR is valued correctly.
  • 83.33% of the companies in the same industry are more expensive than CHR, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CHR to the average of the S&P500 Index (24.95), we can say CHR is valued rather cheaply.
Industry RankSector Rank
PE 10.04
Fwd PE 12.05
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CHR is valued cheaper than 83.33% of the companies in the same industry.
  • CHR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHR is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.37
EV/EBITDA 4.15
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • CHR's earnings are expected to decrease with -3.34% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.34%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • CHR has a Yearly Dividend Yield of 1.43%.
  • CHR's Dividend Yield is a higher than the industry average which is at 0.90.
  • CHR's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.43%

5.2 History

  • The dividend of CHR is nicely growing with an annual growth rate of 21.58%!
  • CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 2026 1 2 3

5.3 Sustainability

  • CHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-5.89%
EPS Next 2Y-3.34%
EPS Next 3YN/A
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

More info and screens

Find the best dividend stocksShow peers with best dividend

CHORUS AVIATION INC

TSX:CHR (3/3/2026, 7:00:00 PM)

24.1

+0.33 (+1.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners1.28%
Ins Owner ChangeN/A
Market Cap564.42M
Revenue(TTM)N/A
Net Income(TTM)-34.96M
Analysts78.18
Price Target31.18 (29.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.43%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)2.39%
PT rev (3m)3.05%
EPS NQ rev (1m)0.52%
EPS NQ rev (3m)2.65%
EPS NY rev (1m)0%
EPS NY rev (3m)5.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-1.6%
Valuation
Industry RankSector Rank
PE 10.04
Fwd PE 12.05
P/S 0.42
P/FCF 17.37
P/OCF 7.93
P/B 1.02
P/tB 1.03
EV/EBITDA 4.15
EPS(TTM)2.4
EY9.96%
EPS(NY)2
Fwd EY8.3%
FCF(TTM)1.39
FCFY5.76%
OCF(TTM)3.04
OCFY12.62%
SpS57.62
BVpS23.67
TBVpS23.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.75
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROCE 8.63%
ROIC 6.4%
ROICexc 6.56%
ROICexgc 6.62%
OM 6.81%
PM (TTM) N/A
GM 65.68%
FCFM 2.41%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Debt/EBITDA 1.32
Cap/Depr 32.58%
Cap/Sales 2.87%
Interest Coverage 2.74
Cash Conversion 33.79%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.63
Altman-Z 0.94
F-Score6
WACC8.42%
ROIC/WACC0.76
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.94%
EPS 3Y-9.92%
EPS 5Y-3.51%
EPS Q2Q%-5%
EPS Next Y-16.67%
EPS Next 2Y-3.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.33%
Revenue Next Year-4.59%
Revenue Next 2Y-2.59%
Revenue Next 3Y-2.14%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year87.94%
EBIT Next 3Y16.24%
EBIT Next 5Y9.99%
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHR.CA.


Can you provide the valuation status for CHORUS AVIATION INC?

ChartMill assigns a valuation rating of 6 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for CHR stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 10.04 and the Price/Book (PB) ratio is 1.02.


How financially healthy is CHORUS AVIATION INC?

The financial health rating of CHORUS AVIATION INC (CHR.CA) is 4 / 10.